Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DX25F6NAK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $12,513
Award facts
- Contract value 100% obligated
- $12,513.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL. The contract is valued at $12,513.37 under a firm fixed-price arrangement with no set-aside designation, reflecting a competitively awarded procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of May 5, 2025. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The company's SPE2DX prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic drugs, vaccines, specialty medications, and medical devices to support Defense Health Agency requirements and other government healthcare systems worldwide. The award of this delivery order for HUMIRA, a critical immunosuppressant therapy, demonstrates AmerisourceBergen's continued role as a primary vendor for specialized pharmaceutical products within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DX25F6NAK?
SPE2DX25F6NAK was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on May 2, 2025.
How much is contract SPE2DX25F6NAK worth?
The government has obligated $12,513 on SPE2DX25F6NAK.
Is contract SPE2DX25F6NAK an order under another contract?
Yes. SPE2DX25F6NAK is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6NAK competed?
The extent of competition for SPE2DX25F6NAK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award